Picture of Raphael Pharmaceutical logo

RAPH Raphael Pharmaceutical Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
R2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.1530.2880.230.0190.045
Total Other Current Assets
Total Current Assets0.4220.3310.2370.0250.051
Net Property, Plant And Equipment0.0020.0020.0020.002
Total Assets0.4220.3330.2390.0270.053
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.2940.2270.1320.7691.49
Total Long Term Debt
Total Debt
Total Liabilities0.2940.2270.1320.7691.49
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.1280.1060.107-0.742-1.43
Total Liabilities & Shareholders' Equity0.4220.3330.2390.0270.053
Total Common Shares Outstanding